Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ribomunyl

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Upper respiratory tract infection is a frequent cause of morbidity worldwide. Although the course of infection is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Purpose: A phase I/II trial was conducted to evaluate clinical and immunologic responses after intralymphatic and intranodal… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2006
2006
Ribomunyl is an immunostimulant that was developed and commercialized in the 1980s in France and has subsequently been made… Expand
Is this relevant?
2005
2005
The maturation state of (monocyte-derived) dendritic cells (DCs) determines the type of T-cell response. Currently, several… Expand
Is this relevant?
2005
2005
Monocyte-derived dendritic cells (MoDCs) in clinical use for cancer immunotherapy are ideally generated in serum-free medium (SFM… Expand
Is this relevant?
2004
2004
Dendritic cells (DC) become fully functional upon maturation by various stimuli. We tested whether an immunostimulatory effect of… Expand
Is this relevant?
2004
2004
IntroductionDendritic cells (DCs) are antigen-presenting cells that are currently employed in cancer clinical trials. However, it… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2002
2002
Dendritic cells (DC) are essential for the generation of primary adaptive immune responses, but their full immunostimulatory… Expand
Is this relevant?
1995
1995
Ribomunyl, an immunomodulating agent, administered to mice 24 h before irradiation, has a radioprotective effect. Ribomunyl… Expand
Is this relevant?
1993
1993
Several functions of polymorphonuclear cells (PMNs) require adhesion to occur. Various membrane proteins' functions such as CD18… Expand
Is this relevant?